Global Companion Diagnostics market | Inkwood Research

1. GLOBAL COMPANION DIAGNOSTICS MARKET FORECAST 2018-2026 • 1

2. GLOBAL COMPANION DIAGNOSTICS MARKET FORECAST 2018-2026 MARKET OVERVIEW • The global companion diagnostics market is segmented on the basis of technology, products and services, indications and end-users. • The technology segment includes polymerase chain reaction, in situ hybridization, immunohistochemistry, next-generation sequencing and other technologies. • The product and service segment includes assay kits and reagents and software and service. • The indication segment is further classified into oncology, neurology, infectious diseases and other indications. • The market caters to end-users like pharmaceutical and biopharmaceutical companies, reference laboratories and other end users.

3. KEY FINDINGS • The global companion diagnostics market is driven by factors such as the widespread of cancer disease across the globe, high demand for target therapies and strategic initiatives for companion diagnostics test development. • By the end of the forecast period of 2018-2026, the market is expected to rise with a 18.45% CAGR. INTRODUCTION Global Companion Diagnostics market by Products and Services, by Indication, by End user, by Technology& by geography.

4. Infographic

5. REQUESTFREESAMPLE To know more about the latest trends and innovation in the Global Companion Diagnostics market Request free sample 5

6. NORTH AMERICA COMPANION DIAGNOSTICS MARKET • The North America companion diagnostics market is projected to rise with a CAGR of 18.62% over the forecast period of 2018-2026. • Initiatives to promote precision medicine research along with the strategic alliances between key market players for companion diagnostics test development are factors that are responsible for propelling the market growth. Request free sample 6

7. EUROPE COMPANION DIAGNOSTICSMARKET • High demand for target therapy and growing efforts to develop advanced companion diagnostics tests are factors that are driving growth in the Europe companion diagnostics market. • Over the forecast period of 2018-2026, the Europe companion diagnostic market is expected to register a CAGR of 18.17%. Request free sample 7

8. ASIA PACIFIC COMPANION DIAGNOSTICSMARKET • The Asia-Pacific companion diagnostics market is predicted to show the highest CAGR of 18.79% over the forecast period of 2018-2026. • China, India and Japan are the major contributors to this market. Request free sample 8

9. COMPETITIVE INSIGHTS Leading players in the global companion diagnostics market are Abbott Laboratories, Almac Group, Arup Laboratories, Biocartis, Biomerieux S.A, Danaher Corporation, Ge Healthcare, Genomic Health, Illumina Inc, Myriad Genetics Inc, Qiagen N.V, Roche Diagnostics (A Hoffmann-La Roche Ag Divison), Sysmex Corporation, and Thermo Fisher Scientific Inc. 9

10. ABOUT US Inkwood Research specializes in syndicated research reports, customized research reports and consulting services. We offer market intelligence studies across a range of industries including Technology, Chemicals, Materials, Healthcare and Energy. With 20 years of research experience, we ensure you efficient deliverables with global and country industry knowledge and research expertise. Our analysis covers North & South America, Europe, CEE, CIS, Middle East, Africa and Asia. 9

11. CONTACT US +1 857-302-4704 sales@inkwoodresearch.com https://www.inkwoodresearch.com/ 10

12. THANK YOU Follow us on: 12